The plasma IL-6 concentration was proposed to be a T2DM and cardiovascular disease marker associated with an inflammatory state, and increased systemic IL-6 concentrations have been correlated with increased fat mass in both rodent models and obese humans (4,10) . Here, IL6 is linked to type 2 diabetes mellitus.